slow arrhythmia
Conditions
Interventions
2:Shen Xian Sheng Mai oral liquid
Sponsors
Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The heart rate is 40–60 beats per minute; 2. Diagnostic criteria in line with slow arrhythmias (Sinus bradycardiaSick sinus syndromeAtrioventricular block); 3. Syndrome of yang-deficiency and slow pulse for TCM; 4. Aged 18 to 75-year-old; 5. SBP 90mmHg to 160mmHg, DBP 60mmHg to 100mmHg; 6. Disable other Anti-arrhythmic drugs more than one weeks. 7. Voluntary subjects and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Serious condition be combined with other Anti-arrhythmia drug treatment (acute myocardial infarction, Acute myocarditis, Drug induced); 2. Patients with syncope caused by a severe bradycardia, bradycardia, bradycardia-tachycardia Syndrome or Atrial Fibrillation; Patients who can not be excluded malignant arrhythmia; 3. Patients have been installed or need to install a pacemaker; 4. Patients with AMI (acute myocardial infarction) or PCI (percutaneous coronary intervention) or CABG (Coronary artery bypass grafting) surgery within 3 months; 5. Unstable blood pressure control (SBP>=160mmHg; DBP>=100mmHg or SDP<90mmHg, DBP <60mmHg); 6. Special Populations (Pregnancy, prepare for pregnancy, lactation women, or incapacity or loss of part of the incapacitated person, such as mental illness, blind, deaf, mute, limb disability, etc.) not suitable for clinical study; 7. Allergic to study drug ingredients; 8. involved in other clinical trials in recent 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Holter; | — |
Secondary
| Measure | Time frame |
|---|---|
| ECG;Adverse effects rate; | — |
Countries
China
Contacts
Public ContactJing Li
Outcome results
None listed